Thromb Haemost 1998; 80(01): 208-209
DOI: 10.1055/s-0037-1615171
Letters to the Editor
Schattauer GmbH

Plasma Hypercoagulability Is Correlated to Plasma HIV Load*

Marina Karmochkine
1   Service de Médecine Interne
,
Annick Ankri
2   Laboratoire d’Hématologie
,
Vincent Calvez
3   Laboratoire de Virologie, Hôpital de la Pitié-Salpêtrière, Paris, France
,
Manuela Bonmarchant
1   Service de Médecine Interne
,
Anne Coutellier
1   Service de Médecine Interne
,
Serge Herson
1   Service de Médecine Interne
› Author Affiliations
This work was supported by a grant from “Sidaction”, Fondation pour la Recherche Médicale.
Further Information

Publication History

Received 11 February 1998

Accepted after revision 01 April 1998

Publication Date:
08 December 2017 (online)

 

 
  • References

  • 1 Brew BJ, Miller J. Human immunodeficiency virus type 1-related transient neurological deficits.. Am J Med 1996; 101: 257-61.
  • 2 Cohen JR, Lackner R, Wenig P, Pillari G. Deep venous thrombosis in patients with AIDS.. NY State J Med 1990; 90: 159-61.
  • 3 Bauer KA, Rosenberg RD. The pathophysiology of the prethrombotic state in humans: insights gained from studies using markers of the hemostatic system activation.. Blood 1987; 70: 343-50.
  • 4 Manucci PM, Tripodi A, Bottasso B, Baudo F, Finazzi G, De Stefano V, Palareti G, Manotti C, Mazzucconi MG, Castaman G. Markers of procoagulant imbalance in patients with inherited thrombophilic syndromes.. Thromb Haemost 1992; 67: 200-2.
  • 5 Boffa MC. Considering cellular thrombomodulin distribution and its modulating factors can facilitate the use of plasma thrombomodulin as a reliable endothelial marker.. Hemostasis 1996; 26 (Suppl. 04) 233-43.
  • 6 Carr A, Brown D, Cooper DA. Portal vein thrombosis in patients receiving indinavir, an HIV protease inhibitor.. AIDS 1998; 11: 1657-8.